Taro Receives FDA Warning Letter Following Inspection Of Its Canadian Manufacturing Facility (PharmaceuticalOnline)
Taro Pharmaceutical Industries Ltd. announced that yesterday, February 5, 2009, it received a warning letter from the U.S. Food and Drug Administration ("FDA") regarding the inspection of the Company's Canadian manufacturing facility in July 2008. This is the first such letter that the Company or any of its affiliates has ever received.

FDA and Kaplan EduNeering Expand Partnership (Business Wire via Yahoo! Finance)
PRINCETON, N.J.----Kaplan EduNeering, a leading provider of compliance and knowledge management solutions and the US Food and Drug Administration have expanded their Cooperative Research and Development Agreement to support the educational needs of government regulatory agencies outside the US using unique technology and content specific to FDA regulations.

Peanut Company at Center of Outbreak Shuts Its Texas Plant After Salmonella Is Found (Washington Post)
A second peanut-processing plant owned by the company at the heart of a nationwide outbreak of salmonella-related illness has been shut down after Texas authorities discovered the bacteria in products there.